UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of protein kinase C activation and the vascular complications of diabetes

Pharmacological research, 2007-06, Vol.55 (6), p.498-510

2007

Volltextzugriff (PDF)

LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1

Acta pharmacologica Sinica, 2017-07, Vol.38 (7), p.1009-1023

2017

Volltextzugriff (PDF)

Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice

Acta pharmacologica Sinica, 2014-08, Vol.35 (8), p.1005-1014

2014

Volltextzugriff (PDF)

Identification of PKC-isoform-specific biological actions using pharmacological approaches

Trends in Pharmacological Sciences, 2000-05, Vol.21 (5), p.181-187

2000

Volltextzugriff (PDF)

Protein kinase C and the development of diabetic vascular complications

Diabetic medicine, 2001-12, Vol.18 (12), p.945-959

2001

Volltextzugriff (PDF)

Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications

The Annals of pharmacotherapy, 2005-10, Vol.39 (10), p.1693

2005

Volltextzugriff (PDF)

Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications

Fundamental & clinical pharmacology, 2008-06, Vol.22 (3), p.231-240

2008

Volltextzugriff (PDF)

Salt form selection and characterization of LY333531 mesylate monohydrate

International journal of pharmaceutics, 2000-04, Vol.198 (2), p.239-247

2000

Volltextzugriff (PDF)

Inhibitory action of protein kinase Cβ inhibitor on tetrodotoxin-resistant Na + current in small dorsal root ganglion neurons in diabetic rats

Neuroscience letters, 2007-04, Vol.417 (1), p.90-94

2007

Volltextzugriff (PDF)

Protein Kinase C β Inhibitor LY333531 Attenuates Intercellular Adhesion Molecule-1 and Monocyte Chemotactic Protein-1 Expression in the Kidney in Diabetic Rats

Journal of Pharmacological Sciences, 2006, Vol.101(4), pp.335-343

2006

Volltextzugriff (PDF)

Role of protein kinase C in diabetic complications

Expert Review of Endocrinology & Metabolism, 2010-01, Vol.5 (1), p.77-88

2010

Volltextzugriff (PDF)

Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development

The cancer journal (Sudbury, Mass.), 2000-07, Vol.6 (4), p.192

2000

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)
Japanisch
(6)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The role of protein kinase C activation and the vascular complications of diabetes

LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1

Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice

Identification of PKC-isoform-specific biological actions using pharmacological approaches

Protein kinase C and the development of diabetic vascular complications

Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications

Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications

Salt form selection and characterization of LY333531 mesylate monohydrate

Inhibitory action of protein kinase Cβ inhibitor on tetrodotoxin-resistant Na + current in small dorsal root ganglion neurons in diabetic rats

Protein Kinase C β Inhibitor LY333531 Attenuates Intercellular Adhesion Molecule-1 and Monocyte Chemotactic Protein-1 Expression in the Kidney in Diabetic Rats

Role of protein kinase C in diabetic complications

Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development

Suchergebnisse filtern